Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-associated Fatty Liver Cirrhosis”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableLooking for participantsNCT07685353
What this trial is testing

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Who this might be right for
Chronic Liver Disease and Cirrhosis
Institute of Liver and Biliary Sciences, India 50
Not applicableLooking for participantsNCT07658755
What this trial is testing

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more
Hospital General Universitario Gregorio Marañon 3,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07663643
What this trial is testing

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 459
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT07325526
What this trial is testing

Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Who this might be right for
Liver Cirrhosis
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Looking for participantsNCT07335601
What this trial is testing

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 120
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Not applicableStudy completedNCT05804955
What this trial is testing

Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)

Who this might be right for
Fatty Liver
University of Campania Luigi Vanvitelli 260
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Not applicableNot Yet RecruitingNCT07834905
What this trial is testing

Nutritional Indices and Inflammatory Markers in MASLD

Who this might be right for
Liver FibrosisMalnutritionNon-Alcoholic Fatty Liver Disease
Assiut University 180
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Large-scale testing (Phase 3)Looking for participantsNCT07701993
What this trial is testing

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 1,740
Next Page
15